Literature DB >> 24637730

Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease.

Zobair M Younossi1, Li Zheng, Maria Stepanova, Linda Henry, Chapy Venkatesan, Alita Mishra.   

Abstract

BACKGROUND AND AIM: Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease. The objective of this study was to describe the recent trend of health care resource utilization and short-term mortality of Medicare beneficiaries with NAFLD.
METHODS: This study utilized data from a random sample of national outpatient claims of Medicare beneficiaries (2005 to 2010) who sought outpatient care for NAFLD.
RESULTS: This study included 29,528 patients who sought outpatient care for NAFLD from 2005 to 2010. The annual number of patients increased consistently from 3585 in 2005 to 6646 in 2010. The prevalence of studied comorbidities including cardiovascular disease, diabetes, hyperlipidemia, and hypertension also increased significantly. At the same time, the mean yearly charge and the mean yearly payment increased significantly from $2624±$3308 and $561±$835 in 2005 to $3608±$5132 and $629±$1157 (P<0.05), respectively. The observed mortality rate remained stable around 2.84% (P=0.64). After adjusting for the other covariates, the total number of outpatient visits and all the comorbidities considered were the most determinant factors for yearly charge and yearly payment (P<0.0001). Overall mortality was associated with age, gender, number of outpatient visits, diabetes, and hyperlipidemia.
CONCLUSIONS: The number of outpatient visits because of NAFLD rose between 2005 and 2010. Short-term mortality rates remained stable throughout the study period, whereas total annual charges and payments increased.

Entities:  

Mesh:

Year:  2015        PMID: 24637730     DOI: 10.1097/MCG.0000000000000071

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  20 in total

Review 1.  Current and Future Burden of Chronic Nonmalignant Liver Disease.

Authors:  Prowpanga Udompap; Donghee Kim; W Ray Kim
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-17       Impact factor: 11.382

2.  Metabolic Syndrome Is Associated with Health-Related Quality of Life in Suspected Patients with Nonalcoholic Steatohepatitis.

Authors:  Ali Gholami; Farhad Zamani; Bayan Hosseini; Rahim Sharafkhani; Mansooreh Maadi; Zahra Moosavi Jahromi; Maryam Khazaee-Pool; Masoudreza Sohrabi
Journal:  Med Princ Pract       Date:  2018-02-05       Impact factor: 1.927

3.  Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.

Authors:  Zobair M Younossi; Rohit Loomba; Quentin M Anstee; Mary E Rinella; Elisabetta Bugianesi; Giulio Marchesini; Brent A Neuschwander-Tetri; Lawrence Serfaty; Francesco Negro; Stephen H Caldwell; Vlad Ratziu; Kathleen E Corey; Scott L Friedman; Manal F Abdelmalek; Stephen A Harrison; Arun J Sanyal; Joel E Lavine; Philippe Mathurin; Michael R Charlton; Zachary D Goodman; Naga P Chalasani; Kris V Kowdley; Jacob George; Keith Lindor
Journal:  Hepatology       Date:  2018-07       Impact factor: 17.425

4.  Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: A prospective cohort study.

Authors:  Elliot B Tapper; Michelle Lai
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

5.  Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA.

Authors:  Alexander L Nguyen; Haesuk Park; Pauline Nguyen; Edward Sheen; Yoona A Kim; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2018-10-16       Impact factor: 3.199

Review 6.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

Review 7.  Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease.

Authors:  Zobair M Younossi; Linda Henry
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981

8.  Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data From a Large U.S. Claims Database.

Authors:  Alina M Allen; Holly K Van Houten; Lindsey R Sangaralingham; Jayant A Talwalkar; Rozalina G McCoy
Journal:  Hepatology       Date:  2018-09-20       Impact factor: 17.425

9.  Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study.

Authors:  Mark G Swain; Alnoor Ramji; Keyur Patel; Giada Sebastiani; Abdel Aziz Shaheen; Edward Tam; Paul Marotta; Magdy Elkhashab; Harpreet S Bajaj; Chris Estes; Homie Razavi
Journal:  CMAJ Open       Date:  2020-06-09

10.  Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States.

Authors:  Ilya Golovaty; Phyllis C Tien; Jennifer C Price; Lila Sheira; Hilary Seligman; Sheri D Weiser
Journal:  J Nutr       Date:  2020-01-01       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.